{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T03:39:41Z","timestamp":1789011581925,"version":"build-2803163510"},"reference-count":37,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Merck and Co. Inc."},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1K23AI119133"],"award-info":[{"award-number":["1K23AI119133"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA18029"],"award-info":[{"award-number":["CA18029"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL093294"],"award-info":[{"award-number":["HL093294"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.bbmt.2016.12.620","type":"journal-article","created":{"date-parts":[[2016,12,28]],"date-time":"2016-12-28T10:45:22Z","timestamp":1482921922000},"page":"505-511","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Herpes Zoster in Autologous Hematopoietic Cell Transplant Recipients in the Era of Acyclovir or Valacyclovir Prophylaxis and Novel Treatment and Maintenance Therapies"],"prefix":"10.1016","volume":"23","author":[{"given":"Farah","family":"Sahoo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7665-7100","authenticated-orcid":false,"given":"Joshua A.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hu","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Leisenring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise E.","family":"Kimball","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingi","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachiko","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6333-5196","authenticated-orcid":false,"given":"Stephen A.","family":"Pergam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary E.","family":"Flowers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Li","family":"Liaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leona","family":"Holmberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Boeckh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2016.12.620_bib0010","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1056\/NEJMoa1114083","article-title":"Lenalidomide after stem-cell transplantation for multiple myeloma","volume":"366","author":"McCarthy","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2016.12.620_bib0015","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1182\/blood-2011-09-379164","article-title":"Administration of bortezomib before and after autologous stem cell transplantation improves outcome in multiple myeloma patients with deletion 17p","volume":"119","author":"Neben","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.12.620_bib0020","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1177\/1078155213514468","article-title":"Multiple myeloma maintenance therapy: a review of the pharmacologic treatment","volume":"21","author":"Shank","year":"2015","journal-title":"J Oncol Pharm Pract"},{"key":"10.1016\/j.bbmt.2016.12.620_bib0025","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1399-3062.2011.00655.x","article-title":"Onset and complications of varicella zoster reactivation in the autologous hematopoietic cell transplant population","volume":"13","author":"Rogers","year":"2011","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.bbmt.2016.12.620_bib0030","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s00277-013-1913-z","article-title":"Impact of the duration of antiviral prophylaxis on rates of varicella-zoster virus reactivation disease in autologous hematopoietic cell transplantation recipients","volume":"93","author":"Truong","year":"2014","journal-title":"Ann Hematol"},{"key":"10.1016\/j.bbmt.2016.12.620_bib0035","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1182\/blood.V74.4.1424.1424","article-title":"Herpes zoster infection after autologous bone marrow transplantation","volume":"74","author":"Schuchter","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.12.620_bib0040","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1002\/1097-0142(19920201)69:3<784::AID-CNCR2820690328>3.0.CO;2-M","article-title":"Long-term sequelae of autologous bone marrow or peripheral stem cell transplantation for lymphoid malignancies","volume":"69","author":"Vose","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/j.bbmt.2016.12.620_bib0045","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/bmt.2014.290","article-title":"Varicella zoster virus reactivation after autologous SCT is a frequent event and associated with favorable outcome in myeloma patients","volume":"50","author":"Kamber","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.12.620_bib0050","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1182\/blood-2007-03-077644","article-title":"One-year acyclovir prophylaxis for preventing varicella-zoster virus disease after hematopoietic cell transplantation: no evidence of rebound varicella-zoster virus disease after drug discontinuation","volume":"110","author":"Erard","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.12.620_bib0055","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1093\/infdis\/152.6.1172","article-title":"Infection with varicella-zoster virus after marrow transplantation","volume":"152","author":"Locksley","year":"1985","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bbmt.2016.12.620_bib0060","first-page":"277","article-title":"Varicella zoster infection after bone marrow transplantation: incidence, risk factors and complications","volume":"13","author":"Han","year":"1994","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.12.620_bib0065","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S1083-8791(00)70004-8","article-title":"Varicella-Zoster virus: pathogenesis, immunity, and clinical management in hematopoietic cell transplant recipients","volume":"6","author":"Arvin","year":"2000","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.12.620_bib0070","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S1083-8791(00)70051-6","article-title":"Varicella zoster virus infections following allogeneic bone marrow transplantation: frequency, risk factors, and clinical outcome","volume":"6","author":"Koc","year":"2000","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.12.620_bib0075","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1182\/blood-2005-09-3624","article-title":"Long-term acyclovir for prevention of varicella zoster virus disease after allogeneic hematopoietic cell transplantation\u2013a randomized double-blind placebo-controlled study","volume":"107","author":"Boeckh","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.12.620_bib0080","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ijid.2013.09.020","article-title":"Prophylactic role of long-term ultra-low-dose acyclovir for varicella zoster virus disease after allogeneic hematopoietic stem cell transplantation","volume":"19","author":"Kawamura","year":"2014","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.bbmt.2016.12.620_bib0085","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/bjc.1989.88","article-title":"The prophylactic role of intravenous and long-term oral acyclovir after allogeneic bone marrow transplantation","volume":"59","author":"Selby","year":"1989","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bbmt.2016.12.620_bib0090","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/j.1399-0012.2008.00877.x","article-title":"Clinical efficacy of prophylactic strategy of long-term low-dose acyclovir for Varicella-Zoster virus infection after allogeneic peripheral blood stem cell transplantation","volume":"22","author":"Kim","year":"2008","journal-title":"Clin Transplant"},{"key":"10.1016\/j.bbmt.2016.12.620_bib0095","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/bmt.2010.99","article-title":"A randomized, double-blind, placebo-controlled trial of valacyclovir prophylaxis to prevent zoster recurrence from months 4 to 24 after BMT","volume":"46","author":"Klein","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.12.620_bib0100","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.bbmt.2009.06.019","article-title":"Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective","volume":"15","author":"Tomblyn","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.12.620_bib0105","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.bbmt.2010.07.026","article-title":"An international comparison of current strategies to prevent herpesvirus and fungal infections in hematopoietic cell transplant recipients","volume":"17","author":"Pollack","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.12.620_bib0110","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1001\/jama.2010.491","article-title":"Hematopoietic stem cell transplantation: a global perspective","volume":"303","author":"Gratwohl","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.bbmt.2016.12.620_bib0115","doi-asserted-by":"crossref","first-page":"ofw067","DOI":"10.1093\/ofid\/ofw067","article-title":"Cost of herpes zoster in patients with selected immune-compromised conditions in the United States","volume":"3","author":"Li","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.bbmt.2016.12.620_bib0125","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.4065\/82.11.1341","article-title":"A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction","volume":"82","author":"Yawn","year":"2007","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.bbmt.2016.12.620_bib0130","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/tid.12406","article-title":"A Japanese single-hospital observational trial with a retrospective case-control analysis of varicella zoster virus reactivation after autologous peripheral blood stem cell transplantation","volume":"17","author":"Mawatari","year":"2015","journal-title":"Transpl Infect Dis"},{"issue":"RR\u20135","key":"10.1016\/j.bbmt.2016.12.620_bib0135","first-page":"1","article-title":"Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"57","author":"Harpaz","year":"2008","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.bbmt.2016.12.620_bib0140","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/00005792-198209000-00003","article-title":"Population-based study of herpes zoster and its sequelae","volume":"61","author":"Ragozzino","year":"1982","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.bbmt.2016.12.620_bib0145","first-page":"341","article-title":"VZV T cell-mediated immunity","volume":"342","author":"Weinberg","year":"2010","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.bbmt.2016.12.620_bib0150","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.bbmt.2008.09.004","article-title":"Recovery of varicella-zoster virus-specific T cell immunity after T cell-depleted allogeneic transplantation requires symptomatic virus reactivation","volume":"14","author":"Distler","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.12.620_bib0155","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1182\/blood-2014-04-573048","article-title":"A phase 1\/2 study of an adjuvanted varicella-zoster virus subunit vaccine in autologous hematopoietic cell transplant recipients","volume":"124","author":"Stadtmauer","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.12.620_bib0160","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jcv.2015.10.018","article-title":"Varicella-zoster virus-specific cell-mediated immunity and herpes zoster development in multiple myeloma patients receiving bortezomib- or thalidomide-based chemotherapy","volume":"73","author":"Kim","year":"2015","journal-title":"J Clin Virol"},{"key":"10.1016\/j.bbmt.2016.12.620_bib0165","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jcv.2013.04.024","article-title":"Acyclovir-resistant varicella-zoster virus keratitis in an immunocompetent patient","volume":"58","author":"Gueudry","year":"2013","journal-title":"J Clin Virol"},{"key":"10.1016\/j.bbmt.2016.12.620_bib0170","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/INF.0b013e3181598315","article-title":"Foscarnet salvage therapy for acyclovir-resistant varicella zoster: report of a novel thymidine kinase mutation and review of the literature","volume":"27","author":"Hatchette","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.bbmt.2016.12.620_bib0175","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/00002030-199006000-00014","article-title":"Emergence of acyclovir-resistant varicella zoster virus in an AIDS patient on prolonged acyclovir therapy","volume":"4","author":"Linnemann","year":"1990","journal-title":"AIDS"},{"key":"10.1016\/j.bbmt.2016.12.620_bib0180","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1200\/JOP.2010.000076","article-title":"Perspectives on adherence and persistence with oral medications for cancer treatment","volume":"7","author":"Hohneker","year":"2011","journal-title":"J Oncol Pract"},{"key":"10.1016\/j.bbmt.2016.12.620_bib0185","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.bbmt.2013.11.013","article-title":"Live attenuated varicella-zoster vaccine in hematopoietic stem cell transplantation recipients","volume":"20","author":"Issa","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.12.620_bib0190","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1093\/infdis\/jit344","article-title":"Safety and immunogenicity of heat-treated zoster vaccine (ZVHT) in immunocompromised adults","volume":"208","author":"Mullane","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bbmt.2016.12.620_bib0195","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1386-6532(99)00042-6","article-title":"Laboratory diagnosis of herpes zoster","volume":"14","author":"Sauerbrei","year":"1999","journal-title":"J Clin Virol"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879116311788?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879116311788?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:59:05Z","timestamp":1761058745000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879116311788"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S1083879116311788"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2016.12.620","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Herpes Zoster in Autologous Hematopoietic Cell Transplant Recipients in the Era of Acyclovir or Valacyclovir Prophylaxis and Novel Treatment and Maintenance Therapies","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2016.12.620","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 American Society for Blood and Marrow Transplantation.","name":"copyright","label":"Copyright"}]}}